StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.25−0.11 (-8.09%)

Close on Nov 20, 2026Market cap $79.66MP/E –Yield –

TuHURA Biosciences cash

Cash and short-term investments held at the end of each period.

TuHURA Biosciences's cash was $995.98K at Jun 30, 2026. For fiscal 2025 it was $3.62M, up 135.8% from the year before. Over ten years it grew 70.2% a year on average. The highest annual figure on record is $11.78M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.62M+135.8%
FY2023Jun 30, 2023$1.54M-87.0%
FY2022Jun 30, 2022$11.78M+11.8%
FY2021Jun 30, 2021$10.54M+340.5%
FY2020Jun 30, 2020$2.39M-35.7%
FY2019Jun 30, 2019$3.72M-37.7%
FY2018Jun 30, 2018$5.97M-9.3%
FY2017Jun 30, 2017$6.59M+7.0%
FY2016Jun 30, 2016$6.16M+48.8%
FY2013Dec 31, 2013$4.14M+23164.0%
FY2012Dec 31, 2012$17.78K+18.4%
FY2011Dec 31, 2011$15.02K-38.4%
FY2010Dec 31, 2010$24.38K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$995.98K-88.3%
Q1 FY2026CQ1 2026Mar 31, 2026$6.30M+1.3%
Q4 FY2025CQ4 2025Dec 31, 2025$3.62M+135.8%
Q3 FY2025CQ3 2025Sep 30, 2025$2.70M-11.4%
Q2 FY2025CQ2 2025Jun 30, 2025$8.51M-40.3%
Q1 FY2025CQ1 2025Mar 31, 2025$6.22M-12.2%
Q4 FY2023CQ2 2023Jun 30, 2023$1.54M-87.0%
Q3 FY2023CQ1 2023Mar 31, 2023$3.05M-65.6%
Q2 FY2023CQ4 2022Dec 31, 2022$14.25M+1.3%
Q1 FY2023CQ3 2022Sep 30, 2022$7.09M-63.4%
Q4 FY2022CQ2 2022Jun 30, 2022$11.78M+11.8%
Q3 FY2022CQ1 2022Mar 31, 2022$8.84M-43.8%
Q2 FY2022CQ4 2021Dec 31, 2021$14.06M-18.0%
Q1 FY2022CQ3 2021Sep 30, 2021$19.34M-14.4%
Q4 FY2021CQ2 2021Jun 30, 2021$10.54M+340.5%
Q3 FY2021CQ1 2021Mar 31, 2021$15.72M+216.1%
Q2 FY2021CQ4 2020Dec 31, 2020$17.16M+170.3%
Q1 FY2021CQ3 2020Sep 30, 2020$22.60M+180.4%
Q4 FY2020CQ2 2020Jun 30, 2020$2.39M-35.7%
Q3 FY2020CQ1 2020Mar 31, 2020$4.97M+131.1%
Q2 FY2020CQ4 2019Dec 31, 2019$6.35M+71.4%
Q1 FY2020CQ3 2019Sep 30, 2019$8.06M+107.5%
Q4 FY2019CQ2 2019Jun 30, 2019$3.72M-37.7%
Q3 FY2019CQ1 2019Mar 31, 2019$2.15M-74.7%
Q2 FY2019CQ4 2018Dec 31, 2018$3.70M-66.4%
Q1 FY2019CQ3 2018Sep 30, 2018$3.88M-70.5%
Q4 FY2018CQ2 2018Jun 30, 2018$5.97M-9.3%
Q3 FY2018CQ1 2018Mar 31, 2018$8.51M+305.0%
Q2 FY2018CQ4 2017Dec 31, 2017$11.02M+222.5%
Q1 FY2018CQ3 2017Sep 30, 2017$13.16M+174.1%
Q4 FY2017CQ2 2017Jun 30, 2017$6.59M+7.0%
Q3 FY2017CQ1 2017Mar 31, 2017$2.10M+124.1%
Q2 FY2017CQ4 2016Dec 31, 2016$3.42M+74.6%
Q1 FY2017CQ3 2016Sep 30, 2016$4.80M+71.1%
Q4 FY2016CQ2 2016Jun 30, 2016$6.16M+48.8%
Q3 FY2016CQ1 2016Mar 31, 2016$937.36K-81.9%
Q2 FY2016CQ4 2015Dec 31, 2015$1.96M–
Q1 FY2016CQ3 2015Sep 30, 2015$2.80M–
Q4 FY2013CQ4 2013Dec 31, 2013$4.14M–
Q3 FY2013CQ3 2013Sep 30, 2013$5.17M–

More TuHURA Biosciences figures

See a number that looks wrong?